Jennifer McNealey | VP, IR & Strategy |
Susan Molineaux | Co-Founder, CEO, President & Director |
Keith Orford | SVP, Clinical Development |
Stephanie Wong | VP, Finance and Secretary |
Michael King | JMP Securities LLC |
Matthew Phipps | William Blair & Company |
Yanan Zhu | Wells Fargo Securities |
Good day, ladies and gentlemen and welcome to the Q4, 2017 Calithera Biosciences Earnings Conference Call. [Operator Instructions]. I would now like to turn the call over to Ms. Jennifer McNealey, Vice President of Investor Relations. Ma'am, you may begin.